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IntroductIon
Macrophages (Mfs) are mononuclear phagocytes resident in 
most tissues where they perform vital functions in defense 
against pathogens, maintenance of tissue homeostasis, and 
wound repair (Davies et al., 2013; Varol et al., 2015). Tradition-
ally, peripheral blood monocytes (PBMos) have been viewed 
as precursors of resident tissue Mfs (van Furth and Cohn, 
1968). However, recent studies in mice have demonstrated 
that in many organs Mfs are populations of self-renewing cells, 
established before birth from yolk sac– or fetal liver–derived 
precursors and independent of bone marrow–derived PBMos 
(Schulz et al., 2012; Hashimoto et al., 2013; Sieweke and Allen, 
2013; Hoeffel et al., 2015). Studies on the origin of Mfs in 
humans are scarce (Haniffa et al., 2009); however, we have re-
ported recently that donor alveolar Mfs in transplanted lungs 
were maintained for years (Eguíluz-Gracia et al., 2016), indi-
cating that self-renewing resident Mfs also occur in humans.
Mfs in the mouse intestine have been reported to be an 
exception from this paradigm. It has been shown that during 
steady-state Ly6Chi PBMos expressing low levels of CX3CR1 
constantly migrate to the intestinal lamina propria of mice in 
a CCR2-dependent manner, where they differentiate into 
resident mature CX3CR1hi Mfs with antiinflammatory prop-
erties through a series of short-lived CX3CR1int interme-
diaries (Tamoutounour et al., 2012; Bain et al., 2013, 2014).
We have previously shown that the majority of 
HLA-DR+ mononuclear phagocytes in human small intes-
tine (SI) were mature Mfs expressing CD14, CD68, CD163, 
and CD209 (DC-SIGN) but negative for CD11c and CCR2, 
whereas a minor population expressed CD1c and CD11c 
compatible with being dendritic cells (DCs; Ráki et al., 2006; 
Beitnes et al., 2011, 2012). A less pronounced population co-
expressed CD14 and CD11c, and most of these cells were also 
CCR2+, indicating that they were recently recruited PBMos 
(Beitnes et al., 2012). Importantly, the CD11c+CD14+CCR2+ 
population was selectively expanded in the intestinal mucosa 
of celiac disease patients after gluten challenge, suggesting 
that they were increasingly recruited to SI during local in-
flammation (Beitnes et al., 2012). Moreover, other studies 
of inflammation in the human gut have shown that recently 
elicited CD14+ PBMos, in contrast to tissue-resident regula-
tory Mfs, produce proinflammatory cytokines (Rugtveit et 
al., 1997; Kamada et al., 2008). However, a comprehensive 
analysis of Mfs in steady-state human intestine is lacking, and 
the developmental relationship between PBMos and intesti-
nal Mfs is still unclear.
Macrophages (Mfs) are instrumental in maintaining immune homeostasis in the intestine, yet studies on the origin and het-
erogeneity of human intestinal Mfs are scarce. Here, we identified four distinct Mf subpopulations in human small intestine 
(SI). Assessment of their turnover in duodenal transplants revealed that all Mf subsets were completely replaced over time; 
Mf1 and Mf2, phenotypically similar to peripheral blood monocytes (PBMos), were largely replaced within 3 wk, whereas two 
subsets with features of mature Mfs, Mf3 and Mf4, exhibited significantly slower replacement. Mf3 and Mf4 localized differ-
ently in SI; Mf3 formed a dense network in mucosal lamina propria, whereas Mf4 was enriched in submucosa. transcriptional 
analysis showed that all Mf subsets were markedly distinct from PBMos and dendritic cells. compared with PBMos, Mf sub-
populations showed reduced responsiveness to proinflammatory stimuli but were proficient at endocytosis of particulate and 
soluble material. these data provide a comprehensive analysis of human SI Mf population and suggest a precursor-progeny 
relationship with PBMos.
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By extensive phenotyping, transcriptome profiling, 
and functional analysis of tissue HLA-DR+ mononuclear 
phagocytes, we demonstrated here that under steady-state 
conditions human SI harbors four CD14+ Mf subsets that 
are distinct from DCs. Examining the replacement kinet-
ics of Mfs in transplanted intestine showed that all Mf sub-
sets were replaced by blood-derived precursors within one 
year after transplantation.
reSultS
Human SI contains four distinct subsets of Mfs
Flow cytometric analysis of single-cell suspensions from 
mucosa of duodenal-proximal jejunum (SI) revealed three 
distinct populations of HLA-DR+CD45+ cells that differ-
entially expressed CD14 and CD11c (Fig. 1 A and Fig. S1 
A). CD14+CD11c− Mfs have been shown to comprise the 
majority of HLA-DR+ cells in human SI (Beitnes et al., 
2011), and the CD14+CD11c+ population was previously 
shown to expand in patients with celiac disease when chal-
lenged with gluten, and based on phenotype it was sug-
gested as deriving from PBMos (Beitnes et al., 2012). We 
identified two subsets within the CD14+CD11c+ (CD11c+ 
Mf) gate based on their differential expression levels of 
HLA-DR and CD14 (Fig.  1  A, top right), whereas two 
populations could be identified within the CD14+CD11c− 
(CD11c− Mf) gate based on their differential expression 
of CD11b (Fig. 1 A, bottom right). The subsets were des-
ignated Mf1 (CD14+CD11c+HLA-DRint), Mf2 (CD14+ 
CD11c+HLA-DRhi), Mf3 (CD14+CD11c−CD11b−), and 
Mf4 (CD14hiCD11c−CD11b+). These populations were 
readily distinguished from DCs that expressed CD11c 
but not CD14 (Fig.  1  A). Mf3 constituted the majority 
of CD45+HLA-DR+ cells (median 60.7%), whereas lower 
numbers of Mf1 (4.7%), Mf2 (11.6%), Mf4 (14.4%), and 
DCs (5.5%) were found (Fig.  1  B). Both Mf1 and Mf2 
populations displayed smaller size and lower autofluores-
cence than Mf3 and Mf4 and had morphology similar to 
PBMos, including kidney-shaped nuclei, whereas Mf3 and 
particularly Mf4 had distinctly shaped nuclei, more cyto-
plasm, and autofluorescence, characteristic of mature Mfs 
(Fig. 1, C and D). We then compared phenotypes of SI Mfs 
and DCs with CD14+ PBMos and blood DCs (PBDCs) by 
flow cytometry (Fig. 1 E and Fig. S1 B). CD64, MerTK, 
CD163, CD16, SIRPα, and CD115 were consistently ex-
pressed on all four SI Mf subsets, although at varying levels. 
CX3CR1 was expressed on Mf1, Mf2, and CD14+ PBMos. 
Low CX3CR1 levels on Mf3 and Mf4 and its expression 
on a subset of DCs in tissue and blood was consistent with 
a previous study on skin (McGovern et al., 2014). CD206 
was not expressed on CD14+ PBMos and was nearly ab-
sent on Mf1, but high levels were detected on the other 
Mf populations. Intestinal DCs did not express CD163 
or CD16 and expressed low levels of CD64, CD115, and 
MerTK and variable levels of CD11b, SIRPα, CD206, 
CD1c, and CD103 (Fig.  1 E). Expression of markers on 
PBDCs was largely similar, although CD163 and CD115 
were detected on a subset of PBDCs, and CD206 and 
CD103 were not expressed (Fig. 1 E). Low levels of CD1c 
were detected on Mf1 and CD14+ PBMos, as shown previ-
ously (Schrøder et al., 2016; Borriello et al., 2017), whereas 
higher levels were detected on Mf2. CD103 was dimly ex-
pressed on a subset of Mf2 (Fig.  1  E), compatible with 
reported in vitro induction of this marker on PBMos or 
PBMo-derived DCs by TGF-β and retinoic acid (Schrøder 
et al., 2016; Roe et al., 2017), which are both abundant in 
the intestinal mucosa (Hansson et al., 2002; Di Sabatino et 
al., 2008; Mowat and Agace, 2014).
To control for possible coisolation of PBMos, we 
performed tissue digestion with the addition of sorted, 
CFSE-labeled CD14+ PBMos (CFSE-PBMos; Fig. S1 C; Mc-
Govern et al., 2014). Flow cytometric analysis of single-cell 
suspensions showed that CFSE-PBMos and Mf1 exhibited 
very similar immunophenotypes (Fig. S1 D), but higher ex-
pression of HLA-DR, HLA-DQ, CD64, MerTK, CX3CR1, 
and CD1c on Mf1 indicated that these cells were not PBMos 
co-isolated during tissue processing.
Human SI Mf compartment comprises short- and long-lived 
subsets that differ in marker expression
To assess the possibility that PBMos are precursors of intesti-
nal Mfs, we first examined the expression of proteins that have 
been shown to be differently expressed on PBMos and Mfs 
(Rugtveit et al., 1996; Beitnes et al., 2012). CCR2 and the 
antimicrobial protein calprotectin (heterodimer of S100A8 
and S100A9) were uniformly expressed by CD14+ PBMos 
(Fig. 2, A and B). Nearly all Mf1 and Mf2 expressed both pro-
teins, but their mRNA levels were reduced compared with 
CD14+ PBMos (Fig. 2, A and B). In contrast, only minor frac-
tions of Mf3 and Mf4 expressed these markers (Fig. 2, A and 
B; and Fig. S2 A). CD209, reported as a marker of mature in-
testinal Mfs (Ráki et al., 2006), was present on Mf2 and both 
CD11c− Mf subsets and was not detected on CD14+ PBMos 
or Mf1 (Fig. 2 C). However, we observed intermediate levels 
of CD209 mRNA in Mf1 (Fig. 2 C).
To directly examine whether human SI Mfs are depen-
dent on PBMo recruitment, we next studied the replacement 
of duodenal Mfs after combined duodenum–pancreas trans-
plantation in patients with diabetes mellitus (see Materials 
and methods and Horneland et al. [2015] for details). Relying 
on a mismatch in HLA class I between donors and recipients, 
we could accurately determine the degree of chimerism of 
Mfs in biopsies from donor duodenum obtained 3, 6, and 
52 wk after transplantation (Fig. 2 D). Only data from pa-
tients with no histological signs of rejection were included. As 
shown in Fig. 2 E almost all donor Mf1 and Mf2 cells were 
replaced by recipient cells within 3 wk after surgery, whereas 
in the CD11c− Mf compartment only a minor fraction was 
of recipient origin (median 5.8% Mf3 and 3.4% Mf4). From 3 
to 6 wk posttransplantation the fraction of recipient Mf3 and 
Mf4 increased to 17.7% and 21%, respectively, and at 52 wk 
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Figure 1. Human SI contains four distinct Mf subsets. (A) Representative flow cytometric analysis of human SI Mfs, identifying Mf1 (purple) and Mf2 
(green, top right), Mf3 (red), and Mf4 (blue, bottom right), and DCs (pink, top center) among CD45+HLA-DR+ SI mononuclear phagocytes. Arrows indicate 
sequential gating (see Fig. S1 A for extended gating strategy). Dot plots are representative of all subjects. (B) The proportion of SI mononuclear phagocyte 
subsets given as percentage of all Mfs and DCs (CD45+HLA-DR+) was determined by flow cytometry; bars indicate median values (n = 55). (c) Representa-
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posttransplantation all donor Mfs were replaced by recipient 
Mfs. Mf3 and Mf4 showed comparable replacement at the 
time points analyzed (Fig. S2 B). To determine whether sur-
gical trauma or immunosuppressive regimen could influence 
Mf replacement, we examined the relative representation 
of subsets within the Mf compartment after transplanta-
tion. We found that at week 3 the proportion of Mf1 was 
increased with a corresponding reduction of Mf3 (Fig. S2 
C). This was most likely the result of increased recruitment 
of PBMos caused by surgical trauma. Nevertheless, at 6 and 
52 wk the cell subset ratios were similar to those observed 
in normal SI (Fig.  1 B and Fig. S2 C), suggesting that the 
observed Mf replacement at later time points represented a 
steady-state situation. Fluorescent in situ hybridization and 
immunofluorescence (IF) confocal microscopy of donor SI in 
gender-mismatched patients confirmed a normal distribution 
of Mfs in donor SI after surgery, as well as the persistence of 
donor Mfs at week 6 and their complete replacement 1 yr 
after transplantation (Fig. S2 D).
These experiments showed that human SI Mf compart-
ment, likely derived from PBMos, consisted of short-lived 
Mf1 and Mf2 subsets and long-lived, more mature Mf3 and 
Mf4 subsets.
Mature Mf subsets localize to 
different compartments of the SI
Observed similar replacement rates of Mf3 and Mf4 (Fig. S2 
B) suggested that they are not subsequent stages of Mf dif-
ferentiation but rather represent alternative pathways of Mf2 
maturation in the intestine. To further determine the relation-
ship between Mf3 and Mf4 subsets, we investigated their spa-
tial localization in situ by IF microscopy. We observed CD209 
expression on the majority of Mfs, but not on DCs (Fig. 2 C 
and Fig. S3 A; Ráki et al., 2006). CD209+ Mfs were observed 
throughout the mucosa (Fig. S3 B). CD209+CD11b− Mf3 
constituted the vast majority of Mfs in the upper crypt area 
and in the villi, whereas CD209+CD11b+ Mf4 were mainly 
situated below the crypts and in the submucosa (Fig.  3, A 
and B). We also observed CD209+ cells in the crypt area that 
coexpressed CD11b and CD11c, corresponding to an Mf2 
phenotype (Fig. 3 A, inset c). Consistently, by physically sep-
arating the tissue at the level of muscularis mucosa before the 
digestion step, we found that Mf3 cells were enriched in the 
lamina propria and Mf4 in the submucosa (Fig. 3 C). More-
over, the vast majority of Mfs isolated from the muscle layer 
situated below the submucosa (muscularis propria) expressed 
an Mf4 phenotype (Fig. 3 D), indicating that Mf phenotype 
correlated with tissue localization.
SI Mf subsets are distinguished by their 
gene expression patterns
To further define the SI Mf subpopulations, we performed 
low-cell RNA sequencing on sorted tissue Mfs and DCs, as 
well as CD14+ PBMos isolated from the same donors (n = 
5, DCs were sorted from two of these). To effectively com-
pare with Mfs, DCs were sorted into three subpopulations: 
CD103+SIRPα− (single positive; SP-DC), CD103+SIRPα+ 
(double positive; DP-DC), and CD103−SIRPα+ (CD103− 
DC; Fig. S4 A), as CD103− DCs have been shown to be 
transcriptionally related to CD14+ PBMos (Watchmaker et 
al., 2014). Principal component analysis (PCA) of all subsets 
showed three main clusters of non-DC populations separated 
in component 1 (PC1, 23.35%; Fig.  4  A). CD14+ PBMos 
clustered separately from all SI Mfs. Mf1 was the Mf subset 
most similar to CD14+ PBMos, whereas Mf2, Mf3, and Mf4 
clustered more together, indicating they were closely related. 
All DC subsets clustered together and were separated from 
CD14+ PBMos and Mfs in PC2 (9.24%). CD14+ PBMos 
pretreated with enzymes to control for effect of tissue di-
gestion (PBMo-lib) clustered with the other CD14+ PBMo 
samples. We also included PBMo-differentiated Mfs (in vitro 
Mfs) in our analysis. PCA showed that in vitro Mfs clustered 
close to Mf1 and distant from the other Mf subsets and DCs 
(Fig. 4 A). However, in vitro Mfs were distant from Mf1 in 
PC3 (6.35%; Fig. S4 B). Pearson correlation analysis and hi-
erarchical clustering of the total dataset were consistent with 
PCA in that CD14+ PBMos formed a separate cluster that 
displayed the highest degree of correlation with Mf1 among 
all subpopulations. Mf1 correlated well with Mf2 and less with 
Mf3 and Mf4. Mf2 essentially coclustered with Mf3 and Mf4. 
The three DC subsets formed a separate cluster, and DP-DC 
and CD103− DC subsets showed some correlation with Mf2 
(Fig. 4 B and Fig. S4 C). We validated our SI DC subset data-
set by performing gene set enrichment analysis with recently 
published PBDC and PBMo subpopulation signatures ob-
tained from single-cell RNA sequencing (Villani et al., 2017). 
This showed that none of the subsets were enriched for 
PBMo signatures, and SP-DCs were closely related to con-
ventional (c) DC1 whereas DP-DC and CD103− DC were 
enriched for genes expressed by cDC2 and cDC1 (Fig. S4 D).
We then performed a polytomous analysis to com-
prehensively analyze the transcriptomes of the different cell 
populations in relation to each other (Turro et al., 2011). 
We used unsupervised hierarchical clustering on the whole 
dataset to identify top clusters and constructed the associ-
ated model matrices for subsequent analysis. By using Bayes-
ian modeling, each gene was assigned to the most probable 
tive micrographs of SI Mf subsets sorted by flow cytometry and stained with Hemacolor reagent. n = 2. Bars, 5 µm. (d) Representative dot plots showing 
FSC-A (size), SSC-A (granularity), and autofluorescence of SI Mf subsets and DCs. Autofluorescence was measured as fluorescence excited by a 488-nm 
laser and collected by a 530/30 bandpass filter, where matched fluorochrome was not included. Data are representative of all subjects. (e) Representative 
flow cytometric staining of surface markers on PBDC, CD14+ PBMo (n = 3 or more; gated as in Fig. S1 B), and SI Mf subsets and DCs (n = 4 or more). Gray 
histograms represent FMO controls.
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Figure 2. Human SI Mf compartment comprises short- and long-lived subsets that differ in marker expression. (A) The percentage of CCR2+ cells 
among CD14+ PBMo (n = 5) and SI Mf subsets (n = 10) was determined by flow cytometry (left). Gates were set according to FMO controls. The expression 
of CCR2 mRNA was determined by RNaseq analysis; n = 5 (right). (B) The percentage of calprotectin+ cells among CD14+ PBMo (n = 7) and SI Mf subsets 
(n = 11) was determined by intracellular staining and flow cytometry. Gates were set according to staining with isotype control antibody. The expression 
levels of S100A8 and S100A9 mRNA were determined by RNaseq analysis; n = 5 (right). (c) The median fluorescence intensity (MFI) of CD209 relative to MFI 
of the FMO control on CD14+ PBMo (n = 5) and SI Mf subsets (n = 9) was determined by flow cytometry. The expression of CD209 mRNA was determined 
by RNaseq analysis; n = 5 (right). (A–C, left) Bars represent median values; ns, not significant (t test comparing CD14+ PBMo and Mf1). *, P < 0.05; ***, P < 
0.001; ****, P < 0.0001 (RM-ANO VA of SI subsets). (A–C, right) Expression values (log2FPKM) were mean-centered by transcript. (d) Representative flow cy-
tometric analysis of recipient-specific HLA-A2 staining on Mf subsets from transplanted duodenum 6 wk after transplantation. Numbers on plots represent 
recipient+ cells (mean ± SD from all patients analyzed at this time point; n = 5). Gray histograms represent staining of HLA-DR+ stromal cells from the same 
sample. (e) The percentage of recipient-derived cells in each Mf subset at 3 (n = 6), 6 (n = 5), and 52 wk (n = 6) after transplantation was determined by 
flow cytometry. Bars indicate median values. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001 (two-way ANO VA with RM on population).
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model based on the calculated posterior probability (>0.65). 
We identified in total 6,735 differentially expressed genes for 
models with a common expression pattern in at least two 
cell subsets and grouped them by the corresponding model 
(Fig. 4 C and Tables S1 and S2).
CD14+ PBMos and Mf1 shared the largest number 
of highly expressed genes (cluster 1, n = 982; e.g., RXRA, 
S100A8), related to immune effector process and immune re-
sponse gene ontology (GO) terms, among others (Fig. 4 C 
and Tables S1 and S2). Cluster 2 contained genes common 
to Mf2, CD14+ PBMos, and Mf1 (n = 171), although these 
were expressed at lower levels in the former (e.g., MPO, 
VCAN) and were related to biological processes correspond-
ing to defense responses including cell activation and secre-
tion. Cluster 3, common to Mf1 and Mf2, included 72 genes 
(e.g., FN1, SPP1) involved in cell signaling pathways. Mf1, 
Mf2, and Mf3 expressed common genes (cluster 4, n = 207), 
including CCL18 and CSF3, related to, e.g., regulations of 
cell communication and protein phosphorylation. Cluster 5 
(n = 809) was common to Mf2, Mf3, and Mf4 (e.g., AHR, 
CFH, IL32) and enriched for genes related to localization 
and cytokine–cytokine receptor interaction. Cluster 6 (n = 
345) contained genes expressed in Mf3 and Mf4, which were 
annotated to terms involved in vesicle mediated transport and 
FCGR-dependent activation and phagocytosis. Cluster 7 (n 
= 365) comprised genes expressed in Mf1, DC subsets, and to 
a lesser extent Mf2 (e.g., RPS20, EIF4B, and many ribosomal 
protein genes), which were related to translation and RNA 
processing. Cluster 8 (n = 783) contained genes expressed in 
DC subsets that were associated with cell cycle and mitosis 
(Fig. 4 C and Tables S1 and S2).
In cluster 9 (n = 668), PBMos and Mf1 showed less cell 
cycle activity compared with other cell types. Several genes 
involved in the metabolism of carbohydrates were expressed 
in Mf3, Mf4, and DC subsets (cluster 10, n = 132). Clus-
ters 11 and 12 (n = 29 and n = 158, respectively) comprised 
genes expressed in CD14+ PBMos, Mf4, and DC subsets, 
including those involved in chromatin organization (e.g., 
histone-coding genes). CD14+ PBMos, Mf1, and DC sub-
sets shared cluster 13 (n = 832) comprising genes (e.g., SPI1, 
Figure 3. Mature Mf subsets localize to different compartments of the SI. (A) IF confocal micrograph from SI stained with CD209 (red), CD11c 
(blue), CD11b (green), and Hoechst DNA stain (gray). Dashed line marks the border between lamina propria and submucosa; bar, 50 µm. Individual channels 
from insets a, b, and c are displayed on the right; bars, 25 µm. Arrowheads (inset c) point to CD209+CD11c+CD11bhi (orange) and CD11blo (white) Mf2 cells. 
The micrograph is representative of six individual subjects. (B) The percentage of Mf3 (CD209+CD11c−CD11b−) and Mf4 (CD209+CD11c−CD11b+) among 
total CD209+ cells in different compartments of intestinal mucosa as in A (n = 6). **, P < 0.01; ***, P < 0.001 (two-way RM-ANO VA comparing localization). 
(c) The proportion of Mf3 and Mf4 calculated as percentage of all Mfs and DCs (CD45+HLA-DR+) was determined by flow cytometry in lamina propria 
and submucosa separated before the digestion step (n = 3). (d) Representative flow cytometric analysis of cells isolated from muscularis propria. Arrows 
indicate sequential gating. Dot plots are representative of five subjects.
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Figure 4. SI Mf subsets are distinguished by their gene expression patterns. (A) PCA of top 1,000 differentially expressed genes within CD14+ PBMo, 
PBMo-lib (enzyme-treated CD14+ PBMos), SI Mf, and DC subsets and in vitro differentiated Mfs. (B) Pearson correlation and hierarchical clustering analysis 
of CD14+ PBMo, PBMo-lib, SI Mf, and DC subsets and in vitro Mfs. Fig. S4 D lists all correlation values. (c) Polytomous analysis of differentially expressed 
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MVP, BOD1L1) involved in, e.g., response to hypoxia and 
many proteasome-related genes. Cluster 14 (n = 238) com-
prised genes expressed by CD14+ PBMos, Mf1, and DC sub-
sets as well as Mf2 (e.g., FGR, FYN) related to cell activations 
processes, whereas CD14+ PBMos, Mf3, and Mf4 expressed 
genes (cluster 15, n = 296) annotated to GO terms such as 
cellular localization, organelle organization, and intracellular 
transport (e.g., GOPC, STO ML1, KIF AP3). Lastly, cluster 16 
(n = 663) contained genes that were expressed at higher levels 
in all Mf subpopulations and CD14+ PBMos compared with 
the DC subsets (e.g., CD99, LAMP2, PL1). These genes were 
involved in immune effector processes, exocytosis, and lyso-
somal function (Fig. 4 C and Tables S1 and S2).
Transcriptome profiling showed that SI Mfs comprised 
subpopulations with complex and partly overlapping expres-
sion profiles that were clearly distinct from SI DC subsets, 
CD14+ PBMos, and in vitro Mfs.
Specific gene expression in SI Mf and dc subsets
Next, we asked whether SI Mfs and DCs expressed subset- 
specific genes. After determining subset-specific clusters from 
polytomous analysis for each population, we identified genes 
expressed at minimum two fragments per kilobase of tran-
script per million mapped reads (FPKMs) and more than 
twofold higher than in all other tissue populations. In total 
42 genes, including S100A12, could be attributed to Mf1 
(Fig. 5). By applying these cut-offs, no specific gene signa-
ture was found for Mf2, and only two genes were identified 
for Mf3. For Mf4, we found 32 selectively expressed genes, 
including CCL13, CCL11, and several neuron-related genes 
(LGI2, CCDC141, NPTX2). Interestingly, this population 
also displayed highest expression of BMP2 (Table S1), en-
coding bone morphogenetic protein 2 known to stimulate 
enteric neurons (Muller et al., 2014). Only a few specific 
genes were identified for SIRPα+ DC subsets: four genes in 
DP-DCs and two genes in CD103− DCs (Fig. 5). Lastly, we 
found 45 genes specifically expressed in SP-DCs, including 
cDC1-specific XCR1 (Fig. 5; Crozat et al., 2010). The rela-
tively few genes specifically expressed in Mf subpopulations 
further supported that these subsets were closely related.
SI Mfs are highly proficient at antigen uptake
A crucial characteristic of Mfs is clearing debris and patho-
gens. To assess the ability of Mfs to phagocytose particulate 
material, we incubated SI cells and PBMCs with pHrodo 
green-labeled Escherichia coli particles. Among SI cells, Mf1 
contained the highest percentage of pHrodo+ cells at all time 
points analyzed, whereas minor differences in phagocytic 
ability were observed among Mf2, Mf3, and Mf4 populations 
(Fig. 6 A and Fig. S5 A). All SI Mf subsets were less efficient 
than CD14+ PBMos but superior to DCs (Fig. 6 A and Fig. 
S5 A). Pre-incubation of E. coli particles with human serum 
before the assay strongly increased the percentage of pHrodo+ 
Mfs (opsonized), particularly Mf3 and Mf4, whereas it had 
little effect on phagocytosis by DCs (Fig. 6 B).
Next, to assess endocytosis and intracellular prote-
olysis of protein antigens, we incubated cells with fluoro-
chrome-conjugated ovalbumin (DQ-OVA), which emits 
green fluorescence after proteolysis in lysosomes. Mf1, Mf2, 
and Mf3 captured and processed DQ-OVA comparably to 
CD14+ PBMos and better than Mf4 (Fig. 6 C). Tissue-derived 
DCs appeared to be less efficient than Mfs (Fig. 6 C). Previous 
studies have shown that ovalbumin can be taken up by several 
pathways, including mannose receptor (CD206)-mediated 
endocytosis, scavenger receptor–mediated endocytosis, and 
pinocytosis (Burgdorf et al., 2007). Analysis of the gene ex-
pression data showed that several genes related to endocyto-
sis and lysosomes were differently expressed both among Mf 
subsets and between Mfs and DCs (Fig. S5 B).
This showed that all Mf subsets can efficiently endo-
cytose both particulate and soluble material and indicated 
that SI Mfs and DCs may use different pathways for anti-
gen uptake and processing.
SI Mfs have attenuated cytokine production
Mfs can have both immunosuppressive and immune activating 
properties depending on signals from the microenvironment 
(Davies et al., 2013). We therefore examined spontaneous and 
LPS-induced secretion of both proinflammatory and immu-
nosuppressive cytokines and chemokines from sorted CD14+ 
PBMos, SI Mf subsets, and DCs. Unstimulated Mf1 secreted 
significantly higher amounts of all cytokines and chemokines 
compared with the other tissue-derived subsets and CD14+ 
PBMos (Fig. 7 A). After stimulation with LPS for 21 h, Mf1 
further increased secretion of TNFα, IL-1β, IL-6, IL-10, and 
GM-CSF but produced significantly less CCL2 and IL-8. In 
contrast, the other subsets showed no significant response 
to LPS other than an increase in IL-8 production by DCs 
(Fig. 7 B). The effect of LPS on cytokine secretion by Mf1 
was very modest (median fold change of 1.11–1.45 for cy-
tokines with increased secretion, 0.55 for CCL2, and 0.90 
for IL-8) and much less pronounced than that observed for 
LPS-stimulated CD14+ PBMos and PBMo-lib (Fig.  7  C). 
Pretreating PBMos with Liberase did not affect cytokine se-
cretion (Fig. 7, A and C).
We examined the effect of other TLR ligands by mea-
suring production of TNFα by intracellular flow cytometry 
after 4  h of stimulation. Consistent with the results above 
genes among CD14+ PBMo and SI Mf and DC subsets, grouped into 16 clusters based on top models obtained from unsupervised clustering. Genes were 
assigned to a model based on the highest calculated posterior probability value (>0.65). Expression values are log2FPKM. Top-ranked genes from each 
cluster are listed on the right (full list available in Table S1). (A–C) CD14+ PBMos and SI Mfs were isolated from five donors, SI DC subsets from two of 
these. PBMo-lib were derived from two of the included CD14+ PBMo samples. In vitro Mfs were differentiated from PBMos of two separate healthy donors.
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(Fig. 7, A–C), a small fraction of unstimulated Mf1 produced 
TNFα, which increased significantly in presence of LPS 
(Fig. 7 D). Similarly, stimulation with poly(I:C), flagellin, and 
R848 significantly increased the fraction of Mf1 expressing 
TNFα. Mf2 responded to stimulation to a lesser extent com-
pared with Mf1, whereas Mf3 and Mf4 did not respond to 
any of the TLR ligands tested (Fig. 7 D).
dIScuSSIon
Phenotypic heterogeneity of the Mf compartment has been 
previously shown in human duodenum (Beitnes et al., 2011, 
2012), ileum (Bain et al., 2013), and colon (Ogino et al., 
2013). Here, we showed that in human duodenum–proximal 
jejunum four distinct Mf subpopulations could be identified 
using only HLA-DR, CD14, CD11c, and CD11b expression. 
Based on surface marker expression, Mf1 cells were compa-
rable with CD14hiHLA-DRloCD209loCD163lo, Mf2 with 
CD14hi/loHLA-DRhiCD209loCD163loCD11c+, Mf3 with 
CD14loHLA-DRhiCD209hiCD163hi, and Mf4 with CD14hi 
HLA-DRhiCD209hiCD163hi cells described in terminal 
ileum (Bain et al., 2013). By using functional and transcrip-
tional analyses, we extended these findings showing that the 
SI Mf compartment comprised cells with PBMo-like features 
as well as spatially distinct mature Mf subsets that were hy-
poresponsive to inflammatory stimuli but highly endocytic.
Studies in mice have shown that PBMos constitutively 
enter the intestine and replace mature Mfs through a gradual 
differentiation process (Tamoutounour et al., 2012; Bain et al., 
2013; Schridde et al., 2017). In transplanted human duode-
num, all Mfs were replaced by recipient cells within one year. 
Mf1 and Mf2 were most rapidly replaced (most within 3 wk) 
after transplantation and had a phenotype and morphology 
that resembled PBMos. However, transcriptional profiling 
showed that Mf1 were most similar to PBMos whereas Mf2 
were more similar to Mf3 and Mf4, indicating that Mf1 were 
most recently elicited and Mf2 an intermediary differentia-
tion stage between Mf1 and Mf3/4. Mf3 and Mf4 were more 
slowly replaced in duodenal transplants, had a typical mature 
Mf morphology, and were more autofluorescent compared 
with Mf1 and Mf2. Moreover, expression of markers that are 
typically related to PBMos (CCR2 and calprotectin) and ma-
ture Mfs (CD209) was gradational between the Mf subsets. 
Although we cannot definitively exclude the possibility that 
circulating precursor cells other than PBMos can give rise to 
intestinal Mfs in humans, our data suggest that the Mf com-
partment in human SI comprises a continuum of cells derived 
from PBMos, differentiating through intermediary Mf1 and 
Figure 5. Specific gene expression in SI Mf and dc subsets. Mean 
expression values (log2FPKM) of genes found uniquely in a single SI Mf 
or DC subset in the polytomous analysis. Genes expressed at minimum 
2 FPKM and more than twofold higher than in all other tissue popula-
tions were considered specific. SI Mfs were isolated from five donors, SI DC 
subsets from two of these.
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Mf2 into Mf3/4, similar to that reported for Mfs in mouse 
intestine (Tamoutounour et al., 2012; Bain et al., 2013).
Mf3 and Mf4 were both slowly replaced in duodenal 
transplants and showed compartmentalized localization in the 
tissue, suggesting they represented alternative pathways of Mf 
differentiation in SI. Mf3 comprised the majority of SI Mfs 
and formed a dense network throughout the villous mucosa, 
resembling the steady-state resident CX3CR1hi mouse intes-
tinal Mfs (Kim et al., 2011). In contrast, CD11b+ Mf4 were 
primarily located deep in the mucosa and in the submucosa. 
Additionally, cells expressing Mf4 phenotype constituted the 
majority of Mfs in muscularis propria. Submucosa and mus-
cularis propria are densely innervated, and studies in mice 
have shown that Mfs in muscularis propria are functionally 
different from lamina propria Mfs and interact with enteric 
nervous system (Muller et al., 2014; Gabanyi et al., 2016). 
Moreover, expression of CD11b on microglia has been shown 
to be important for synaptic pruning (Stephan et al., 2012). 
Mf4 preferentially expressed BMP2, suggesting they may be 
homologous to mouse muscularis Mfs (Muller et al., 2014).
Mfs and DCs both belong to the mononuclear phago-
cyte system, share several functional properties (e.g., antigen 
presentation), and express common surface markers. Con-
sequently, such cells have often been inappropriately iden-
tified in the literature (Cerovic et al., 2014; Guilliams and 
van de Laar, 2015), although recent advancements in fate 
mapping and tracing experiments have helped define tissue 
DCs and Mfs in mice (Guilliams et al., 2014; Guilliams and 
van de Laar, 2015). Our analysis of DC and Mf transcrip-
tomes clearly showed that SI DC subsets were distinct from 
SI Mf subsets and PBMos. Comparing our data with a recent 
study on PBDC and PBMo subsets (Villani et al., 2017), we 
corroborated the findings of Watchmaker et al. (2014) that 
SP-DCs correlated with cDC1 and DP-DCs with cDC2. In 
contrast to Watchmaker et al., we did not observe enrichment 
for PBMo-related gene signatures in CD103− DCs; however, 
whether CD103− DCs included PBMo-derived cells was im-
possible to determine from these analyses.
Mfs are believed to play an essential role at mucosal 
sites, both to respond to and eliminate infectious organisms 
and to maintain homeostasis by clearance of debris and dead 
cells (Davies et al., 2013). Here we showed that all Mf sub-
sets were very efficient at endocytosis of both particulate and 
soluble material. Consistently, transcriptional analysis showed 
that Mf2, Mf3, and Mf4 were enriched for genes involved in 
endocytosis, receptor-mediated phagocytosis, and lysosome 
function (clusters 5 and 6). Further, mucosal Mfs were more 
efficient than DCs in uptake and processing of soluble antigen 
(ovalbumin). This is consistent with a previous study showing 
that SI CX3CR1+ Mfs, but not CD103+ DCs, can efficiently 
capture luminal ovalbumin in mice (Mazzini et al., 2014). SI 
DCs and Mfs expressed different genes related to endocytosis 
and lysosome GO terms, which is difficult to correlate with 
our functional data, but suggests a level of specialization in 
uptake and processing of antigens between these cell types. In 
Figure 6. SI Mfs are highly proficient at antigen uptake. (A) The 
percentage of pHrodo green E. coli+ cells among CD14+ PBMo, PBDC 
(left, n = 5), and SI Mf subsets and DCs (right, n = 5) was determined by 
flow cytometry after indicated incubation times. (B) The effect of pre-
incubation with human serum (opsonization) on the uptake of pHrodo 
green E. coli bioparticles by SI Mf subsets and DCs was determined by 
flow cytometry after 15 or 45 min of incubation (n = 5). E. coli bioparti-
cles were opsonized by incubating in 50% inactivated human serum for 
30 min at 37°C. *, P < 0.05; ****, P < 0.0001 (two-way RM-ANO VA com-
paring effect of opsonization at one time point). (c) The percentage of 
DQ-OVA (green)+ cells among CD14+ PBMo, PBDC (left, n = 5), and SI 
Mf subsets and DCs (right, n = 5) was determined by flow cytometry 
after indicated incubation times. (A and C) Data are presented as mean 
± SEM of pHrodo+ (A) or DQ-OVA+ (C) cells within each population (Fig. 
S4 A). Comparisons between subsets are marked in color corresponding 
to compared subset. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 
0.0001 (two-way RM-ANO VA).
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contrast to previous studies (Smythies et al., 2005; Bain et al., 
2013), we observed increased phagocytosis in PBMos com-
pared with SI Mf subsets. This discrepancy may be because 
of inherent differences between SI and colon Mfs, species, or 
differences in the method used.
Mf1 secreted low levels of cytokines without stimula-
tion but responded most strongly to TLR ligands among SI 
subsets. This may suggest that PBMo extravasation through 
endothelium induces a “poised” state of cellular activa-
tion (Takahashi et al., 1996; Williams et al., 2009). Mf1 re-
sponded less strongly to LPS stimulation than PBMos, and 
both spontaneous cytokine production and responsiveness to 
TLR stimulation were further reduced in Mf2, whereas Mf3 
and Mf4 did not respond to any of the TLR ligands tested. 
This apparent hyporesponsiveness suggests that maturation of 
Mfs in the intestine could induce an increased threshold for 
TLR-mediated activation. The poised activation state and op-
sonization-independent high phagocytic activity of Mf1 sug-
gest their potential role in responding to events that disturb 
intestinal homeostasis. However, as high levels of proinflam-
matory cytokines could lead to destruction of tissue integrity 
(Neurath, 2014), the lack of cytokine production and hypore-
sponsiveness to stimulation in Mf3 is likely necessary to main-
tain homeostasis in the intestinal mucosa and an integral part 
of resident intestinal Mf identity.
An essential role of IL-10 in maintenance of intesti-
nal homeostasis has been demonstrated in studies of Il10−/− 
mice that develop spontaneous enterocolitis (Kühn et al., 
1993; Berg et al., 1996; Mao et al., 2012). In humans, the im-
portance of IL-10 is indicated by loss-of-function variants 
of IL-10R that cause severe early-onset inflammatory bowel 
disease (Glocker et al., 2009; Mao et al., 2012; Shouval et 
al., 2014). IL-10 can be produced by various leukocytes, in-
cluding Mfs (Kole and Maloy, 2014). We observed neither 
spontaneous nor induced IL-10 production in mature SI 
Mfs, which is consistent with previous studies reporting a 
lack of IL-10 production by human jejunal Mfs (Smythies 
et al., 2005, 2010). In contrast, colonic Mfs have been shown 
to produce IL-10 in humans (Kamada et al., 2008; Ogino 
et al., 2013) and in mice (Rivollier et al., 2012; Bain et al., 
2013; Krause et al., 2015). Because IL-10+ Mfs are more 
frequent in the mouse colon compared with SI (Krause et 
al., 2015), it is possible that regulation of IL-10 production 
differs between these compartments. A recent study indi-
cated that the capacity of Mfs to respond to, rather than pro-
duce, IL-10 is important to maintain intestinal homeostasis 
(Zigmond et al., 2014).
Multiple studies probing the function of human Mfs 
have often used PBMos matured in vitro as surrogates for 
tissue Mfs. Interestingly, our transcriptional analysis showed 
that in vitro Mfs separated from all SI Mf subsets. This finding 
further underscores the importance of microenvironmental 
factors in differentiation of tissue resident Mfs, especially con-
sidering the spectrum of responsiveness of the PBMo-derived 
cells to various stimuli (Xue et al., 2014). It is likely that 
PBMo-to-Mf differentiation in the intestinal mucosa in-
volves multiple factors in the microenvironment (Okabe and 
Medzhitov, 2016; Joeris et al., 2017).
Together, our results support a model where PBMos con-
stitutively migrate into the intestinal mucosa where they grad-
ually lose their proinflammatory capacity and, via sequential 
short-lived intermediaries (Mf1 and Mf2), differentiate into 
the mature Mf3 or Mf4, likely depending on tissue-specific 
signals in the microenvironment. This study provides an im-
portant basis for future research on human intestinal Mfs, in-
cluding their contribution to inflammation, wound healing, 
and other pathological changes in the intestine.
MAterIAlS And MetHodS
Patients
Tissue samples of human SI were obtained from patients with 
pancreatic cancer, distal bile duct cancer, or periampullary 
carcinoma undergoing the Whipple procedure (pancreati-
coduodenectomy; n = 95, mean age 68 yr, range 39–88 yr, 43 
women). Material analyzed was the distal part of resected SI 
(duodenum–proximal jejunum) from patients without metas-
tases, who had not undergone previous oncological treatment.
Tissue samples from transplanted duodenum were ob-
tained from patients (n = 15) with diabetes mellitus type I 
who had received pancreas–duodenal segment transplanta-
tion either singly or in combination with kidney transplan-
tation. All recipients received standard immunosuppressive 
regimen (Horneland et al., 2015). Biopsies from donor duo-
denum were obtained at 3, 6, and 52 wk posttransplantation. 
Grading of acute cellular rejection was performed at weeks 3 
and 6 by an experienced pathologist according to Ruiz et al. 
(2010), and only patients without signs of cellular rejection 
were included (n = 11).
Buffy coats and blood were collected from healthy do-
nors and patients undergoing the Whipple procedure.
The study was approved by the Norwegian Regional 
Committee for Medical Research Ethics, and all patients gave 
written informed consent.
tissue handling and cell isolation
Pieces of SI obtained from the Whipple procedure were 
opened longitudinally and washed in PBS. Mucosa was dis-
sected in narrow strips from underlying fat and muscle tissue 
and then incubated with shaking in PBS with 2 mM EDTA 
(Sigma-Aldrich) and 1% FCS (Sigma-Aldrich) three times for 
15 min at 37°C. Epithelial cells were removed after each incu-
bation step by filtration through nylon 100-µm mesh. Where 
stated, after epithelial cell removal, lamina propria was isolated 
by tearing off of the underlying submucosa under a micro-
scope, and the two compartments were processed separately 
from this point onward. Tissue was minced and digested with 
stirring for 60 min in complete RPMI (RPMI1640; Lonza; 
supplemented with 10% FCS, 1% Pen/Strep; Lonza) contain-
ing 0.25 mg/ml Liberase TL (Roche) and 20 U/ml DNase 
I (Sigma). Digested cell suspension was passed through a 
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100-µm filter and washed. Mucosal biopsies obtained from 
transplanted patients were processed according to the same 
protocol, starting with EDTA washes. Where stated, CFSE- 
labeled CD14+ PBMos were added to tissue pieces before the 
digestion step. PBMCs were isolated by density centrifuga-
tion over Lymphoprep (Axis-Shield).
Antibodies
The following antibodies were used for flow cytometry. 
CD1c-PE (L161), CD11b-APC/BV421/BV650 (ICRF44), 
CD14-APC-Cy7/PacBlue/PE-Cy7/AF700 (HCD14), 
CD16-PE/AF700 (3G8), CD45-BV510/AF700/APC-Cy7 
(HI30), CD64-PE-Cy7 (10.1), CD115-PE (9-4D2-1E4), 
CD163-APC/PE (GHI/61), SIRPα-PE-Cy7 (SE5A5), 
CCR2-BV421 (K032C2), CX3CR1-PE (2A9-1), HLA-
DQ-FITC/PE (HLA DQ1), and HLA-DR-BV605/
PerCP-Cy5.5/PE-Cy7 (L243) were from BioLegend. 
CD11c-PE/APC (S-HCL-3), CD45-APC-H7 (2D1), 
and CD209-APC (DCN46) were from BD Biosciences. 
MerTK-PE (125518) was from R&D Systems. CD103-PE 
(B-Ly7) and TNFα-AF488 (Mab11) were from eBioscience. 
Calprotectin-PE (MAC387) was from AbD Serotec. Uncon-
jugated CD206 (19.2) was from BD Biosciences and was used 
with secondary goat anti–mouse IgG1-PE from Southern 
Biotech. FcR blocking reagent (Miltenyi Biotec) was added 
with antibodies during staining of surface and intracellular 
antigens to reduce background staining.
Donor- and recipient-derived cells were distinguished 
by using HLA-A2-PE (BB7.2) from Abcam, HLA-A3-APC/
FITC (GAP.A3) from eBioscience, HLA-B7-PE (BB7.1) from 
Millipore, and HLA-B8-PE (REA145) from Miltenyi Biotec.
The following unconjugated (unless otherwise stated) 
primary antibodies were used for microscopy: CD11b 
(2LPM19c; Thermo Scientific), CD11c (CBR-p150/4G1; 
AbD Serotec), CD163 (10D6; Leica), CD209-APC (DCN46; 
BD Biosciences), CD209/DC-SIGN (5D7; Abcam), CD68 
(PG-M1; DAKO), and HLA-DRα (TAL.1B5; DAKO). 
Polyclonal rabbit IgG targeting calprotectin was a gift from 
I. Dahle (Calpro, Oslo, Norway). The following secondary 
goat antibodies were used: anti–mouse IgG1-AF488/AF555/
AF647, anti–mouse IgG2a-AF555, anti–mouse IgG3-AF594, 
and anti–rabbit IgG-AF555 (Invitrogen) and anti–mouse 
IgG2b-AF647, anti–rabbit IgG-AF488, and donkey anti–rabbit 
IgG-AF647 (Molecular Probes).
Flow cytometry
Cells were stained with fluorescently labeled antibodies (pre-
vious section) on ice for 15 min. HLA allotype-specific an-
tibodies were used to distinguish donor and recipient cells 
in the transplanted intestinal tissue. Donor-specific staining 
on stromal cells was confirmed in each experiment. Dou-
blets were discriminated in forward scatter area versus height 
(FSC-A/FSC-H) and side scatter area versus width (SSC-A/
SSC-W) plots. Dead cells were excluded based on propid-
ium iodide, TO-PRO-1, or TO-PRO-3 staining (Molecular 
Probes). BD Cytofix/Cytoperm kit (BD Biosciences) was 
used for intracellular staining and Foxp3/Transcription Fac-
tor Staining Buffer Set (eBioscience) for intranuclear staining, 
and dead cells were excluded by staining with fixable viability 
dyes in eFluor 450 or eFluor 780 (eBioscience). Flow cytom-
etry was performed on BD LSRFortessa (BD Biosciences), 
and data were analyzed with FlowJo software.
cell sorting
For cytokine immunoassay and morphology assessment, SI 
cells were first enriched by using 10 µg/ml anti–HLA-DQ 
antibody (clone FN81; BMA Biomedicals) biotinylated with 
DSB-X Biotin Protein Labeling kit (Molecular Probes) and 
Dynabeads FlowComp Flexi kit (Invitrogen). Remaining 
CD14+ cells were sorted from the HLA-DQ− fraction with 
Dynabeads FlowComp Human CD14 kit (Invitrogen). Bead-
free HLA-DQ+ and HLA-DQ−CD14+ cells were stained 
as described in the previous section, and subpopulations 
were sorted on FAC SAria IIu (BD Biosciences): Mf1 from 
HLA-DQ−CD14+, other Mf subsets and total DCs from 
HLA-DQ+ fraction. For cytokine immunoassay and gener-
ation of CFSE-monocytes, CD14+ PBMos were sorted from 
PBMCs (where specified after incubation with Liberase TL 
and DNase I as described in the Tissue handling and cell iso-
lation section) with CD14 MicroBeads (Miltenyi Biotec). 
For RNA sequencing, SI cell suspension was first separated 
with CD14 MicroBeads, and Mf subsets (n = 5) were sorted 
from CD14+ fraction (0.3–1.25 × 105 cells per subset) on 
FAC SAria IIu. CD14− fraction was further enriched for DC 
by removing CD3+, CD19+, and CD38+ cells by using CD3 
Dynabeads (Invitrogen), Pan Mouse IgG Dynabeads (Invitro-
gen) precoated with unconjugated anti-CD19 (clone HIB19 
from BioLegend), and anti-CD38 (clone HB7 from Abso-
lut Antibody LTd) antibodies as described in the Dynabeads 
Figure 7. SI Mfs have attenuated cytokine production. (A) Spontaneous cytokine release by sorted SI Mf subsets and DCs (n = 8) and CD14+ PBMos 
and PBMo-lib (n = 7) was measured by a Bio-Plex assay in supernatants after 21 h of culture. Bars indicate median values. #, P < 0.05; ##, P < 0.01; ###, P < 
0.001; ####, P < 0.0001 (ANO VA of PBMo, PBMo-lib, and Mf1). **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (RM-ANO VA of SI subsets). (B) Concentration of 
cytokines released spontaneously (dots) and after stimulation with 1 µg/ml LPS (squares) in supernatants after 21 h of culture of sorted SI Mf subsets and 
DCs (n = 5). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (two-way RM-ANO VA). (c) Concentration of cytokines released spontaneously (dots) 
and after stimulation with 1 µg/ml LPS (squares) in supernatants after 21 h of culture of sorted CD14+ PBMos and PBMo-lib (n = 6 or 7). *, P < 0.05; **, P < 
0.01; ***, P < 0.001; ****, P < 0.0001 (two-way RM-ANO VA). (d) The percentage of TNFα+ cells in SI Mf subsets was determined by intracellular staining and 
flow cytometric analysis after 4 h of culture in medium only or containing LPS, flagellin, R848, or poly(I:C) (n = 3). Floating bars represent range, with a line 
indicating median. Dotted line represents background staining on Mf3 and Mf4 based on the fraction of cells found within the isotype control gate. *, P < 
0.05; **, P < 0.01 compared with matched medium-only control (two-way RM-ANO VA).
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manufacturer’s protocol (Direct Technique). 1.15–4.2 × 104 
cells per DC subset were sorted on FAC SAria IIu (n = 2). All 
cells were sorted into complete RPMI, washed in PBS, then 
lysed in 80 µl RLT buffer (QIA GEN RNeasy Micro) con-
taining 1% β-mercaptoethanol (Sigma) and stored at −80°C 
until use. CD14+ PBMos from the same donors were sorted 
from PBMCs by using the Dynabeads Untouched Human 
Monocytes kit (Invitrogen) where stated, including enzy-
matic treatment as in the Tissue handling and cell isolation 
section. 0.4–1.6 × 105 CD14+ PBMos have been lysed in 
80  µl RLT buffer containing 1% β-mercaptoethanol and 
stored at −80°C until use.
Microscopy
To assess morphology, 2.5–5 × 104 sorted cells were spun 
onto a glass slide, fixed, and stained with a Hemacolor stain 
kit (Merck). Cytospins were viewed by using Olympus BX51 
microscope with ColorView IIIu camera (Olympus).
For combined fluorescence in situ hybridization 
(FISH)/IF, formalin-fixed biopsies were cut at 4 µm, and 
sections were mounted on slides and incubated overnight at 
56°C. Specimens were then dewaxed in xylene, rehydrated in 
ethanol, and boiled for 20 min in Dako buffer. Sections were 
incubated with CEP X/Y DNA probes (Abbott Molecular) 
overnight at 37°C and subsequently stained with antibodies 
(Antibodies section) according to standard protocol in 1.25% 
BSA. For IF only, cut sections were boiled in citrate buffer 
or stained immediately after thawing (sections from cryopre-
served biopsies), and staining with secondary antibodies was 
performed in presence of 10% human serum. Nuclei were 
counterstained with Hoechst 33258 (Molecular Probes). Im-
ages were acquired on an Olympus FV1000 (BX61WI) sys-
tem with 405-, 488-, 543-, and 633-nm laser lines by using 
20×/0.80 or 60×/1.35 UPlanSApo oil objectives (Olympus).
Immunoenzymatic staining for CD209 was per-
formed on formalin-fixed 4-µm sections, dewaxed in xylene 
and rehydrated in ethanol, by using EnVision FLEX, High 
pH (Dako Autostainer/Autostainer Plus) and the HRP kit 
(DAKO), following manufacturer’s instructions. In brief, 
heat-induced antigen retrieval was performed in Tris/EDTA 
pH9 buffer, followed by peroxidase blocking, staining with 
primary antibody (anti–DC-SIGN, clone 5D7, 10 µg/ml) for 
60 min at room temperature, secondary HRP-conjugated 
antibody for 30 min at room temperature, and incubation 
with substrate (DAB) for 7 min at room temperature, with 
wash steps in between. Slides were then stained with hema-
toxylin and eosin and scanned by using Pannoramic Midi 
slide scanner (3DHI STE CH).
cytokine measurement
1.5–3 × 104 SI cells or CD14+ PBMos, sorted into popula-
tions as described, were cultured in 200 µl complete RPMI 
in 96-well round bottom plates for 21  h at 37°C with or 
without 1 µg/ml LPS (Sigma). Cells and debris were removed 
by centrifugation, and collected supernatants were kept at 
−80°C until use. Measurement of TNFα, IL-1β, IL-6, IL-8, 
IL-10, IL-12p70, GM-CSF, CCL2, and CCL4 in culture su-
pernatants was done with a custom premixed Bio-Plex assay 
(Bio-Rad). Cytokine concentrations in the supernatants were 
normalized by multiplying the obtained concentrations by 
a factor equal to 3 × 104/x, where x is the number of cells 
plated in a given well. For flow cytometry assay, 5 × 106 SI 
cells were cultured for 4 h in complete RPMI in ultra-low 
attach plates and treated with LPS, 1 µg/ml flagellin (Invivo-
Gen), 5 µg/ml poly(I:C) (Sigma), or 1 µg/ml R848 (Tocris 
Bioscience). Cytokine secretion was blocked with GolgiStop 
(BD Biosciences) added 30 min after start of the culture.
Assessment of antigen uptake
3 × 106 cells were incubated with 50 µg/ml DQ-OVA 
(Molecular Probes) or with 1 mg/ml pHrodo Green E. coli 
bioparticles (Molecular Probes) for specified times at 37°C or 
on ice. Where stated, pHrodo Green E. coli bioparticles were 
opsonized by incubation in 50% inactivated human serum for 
30 min at 37°C, washed, and resuspended in fresh serum-free 
buffer before the assay. After incubation, cells were washed, 
stained with antibodies, and analyzed by flow cytometry by 
comparing fractions of green fluorescent cells incubated at 
37°C and on ice for the same amount of time.
In vitro Mfs
Differentiation was performed as described (Saeed et al., 
2014). In brief, buffy coats were obtained from Sanquin in 
Radboudumc. PBMCs were isolated by double gradient 
centrifugation, first over Ficoll-Paque Plus (GE Healthcare 
Life Sciences) and following centrifugation over hyper os-
motic Percoll solution (GE Healthcare Life Sciences). T, B, 
and NK cells were depleted by selection with CD3, CD19, 
and CD56 MicroBeads on LD columns (Miltenyi Biotec) 
and PBMos were further enriched by attachment to plastic 
after culture in RPMI 1640 supplemented with 1% Pen/
Strep and 10% human serum (Sigma Aldrich) as a source of 
M-CSF, for 1 h at 37°C and 5% CO2 and removal of floating 
cells. Mfs were obtained after culturing PBMos for 7 d with a 
change of medium every 3 d.
rnA isolation and library construction
For RNA sequencing SMA RT-seqII protocol was used as 
described before (Picelli et al., 2014). In brief, total RNA was 
isolated by using a column-based kit according to manufacturer’s 
instruction (RNeasy Micro; QIA GEN). RNA with good 
quality, as assessed by Experion Automated Electrophoresis 
System (Bio-Rad), was used for cDNA synthesis by using 
ultra-low input RNA SMA RT-seq v4 kit according to the 
manufacturer’s protocol (Clonetech). Diagenode Pico sonicator 
was used to shear cDNA, and the sonication efficiency was 
evaluated by a 2100 Bioanalyzer (Agilent). A KAPA Hyper 
Prep kit (KAPA Biosystems) was used to make libraries for 
next-generation sequencing by using standard Illumina library 
prep protocol. In brief, sonicated cDNA was end repaired 
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and A-tailed in one reaction for 30 min at 20°C followed by 
deactivation of the enzyme by heating to 65°C for another 30 
min. Then NextFlex ChIP-seq adapters (Bioo Scientific) were 
used to barcode the end-repaired A-tailed samples at 20°C 
for 15 min. Ligated samples were cleaned by using AMPure 
XP beads (Beckman Coulter) with the sample :bead ratio of 
0.8 to remove remaining enzymes and adapters. The libraries 
were amplified for 10 PCR cycles (HIFI HotStart kit; KAPA), 
cleaned with QIAquick PCR purification kit (QIA GEN), and 
subjected to size selection by using the E-Gel electrophoresis 
system size selection approach (Thermo Fisher Scientific) 
to select 300 bp fragments. Libraries were concentrated 
by using vacuum centrifugation (Savant DNA SpeedVac; 
Thermo). Library concentration was quantified by Qubit 2 
(Thermo Fisher Scientific), and the average size of the libraries 
was determined by the 2100 Bioanalyzer. Sequencing was 
performed on Illumina NextSeq 500 platform with paired-end 
reads and a sequencing depth of 35 million reads per end.
Analysis of rnaseq data
Raw data were cleaned from ribosomal RNA contamination 
by using Bowtie (Langmead and Salzberg, 2012), and the reads 
with quality score >15 were chosen for subsequent analysis. 
Processed reads were aligned to human genome (hg19) by 
using Bowtie (Wu and Nacu, 2010) with default options, and 
the expression values were used to remove the possible sam-
ple batch effects as described before (Leek et al., 2017). The 
polytomous analysis was performed by using MMS EQ pipe-
line (Turro et al., 2011) with default options. The functional 
analysis was performed by using g:Profiler (Reimand et al., 
2016). For GO and pathway analysis we used the Gene On-
tology consortium database and KEGG and REA CTO ME 
databases, respectively. Gene set enrichment analysis was per-
formed by using Broad Institute GSEA software (Mootha et 
al., 2003; Subramanian et al., 2005). All other analyses were 
performed in R and Linux.
Statistical analysis
All statistical analyses were performed by using Prism 6.0 
(GraphPad Software). Data were analyzed by two-tailed Stu-
dent’s t test, Mann-Whitney test, one-way ANO VA (standard, 
or repeated measures, RM-ANO VA), followed by Tukey’s 
multiple comparison tests, or two-way RM-ANO VA fol-
lowed by Šídák’s multiple comparison tests. Values of P < 0.05 
were considered significant.
Accession numbers
Sequencing raw data of this study has been deposited under 
a controlled data access at the European Genome-phenome 
Archive (http ://www .ebi .ac .uk /ega /), which is hosted at the 
EBI, under accession no. EGAS00001002093.
online supplemental material
Fig. S1 includes the extended gating of SI Mf subsets and DCs, 
CD14+ PBMos, and PBDCs, CD14 MicroBeads separation 
of PBMCs, and phenotype comparison of CFSE-PBMos and 
Mf1. Fig. S2 (related to Fig. 2) shows phenotype comparison 
of Mf2, Mf3, and CCR2+ Mf3 fraction and additional data re-
lated to Mf replacement, including correlation of Mf3 and Mf4 
replacement, representation of Mf subsets in transplant material, 
and FISH/IF micrographs showing Mf replacement at 6 and 
52 wk in sex-mismatched transplanted duodenum. Fig. S3 (re-
lated to Fig. 3) shows CD209 expression in SI. Fig. S4 (related 
to Fig.  4) includes representation of SI DC subsets, PC3 in 
relation to PC1 and PC2, and gene set enrichment analysis of 
PBDC and PBMo subset signatures in SI DC subsets. Fig. S5 
(related to Fig. 6) explains gating of pHrodo+ populations in 
uptake assays and includes heatmaps of endocytosis and lyso-
some-related genes expressed in SI subsets. Table S1 (related to 
Fig. 4) lists genes included in clusters 1–16. Table S2 (related to 
Fig. 4) includes GO terms and pathways enriched in clusters 
1–16. Tables S1 and S2 are included as Excel files.
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